NO302472B1 - Sulfonylureaforbindelse, farmasöytisk formulering og anvendelse derav - Google Patents

Sulfonylureaforbindelse, farmasöytisk formulering og anvendelse derav

Info

Publication number
NO302472B1
NO302472B1 NO930380A NO930380A NO302472B1 NO 302472 B1 NO302472 B1 NO 302472B1 NO 930380 A NO930380 A NO 930380A NO 930380 A NO930380 A NO 930380A NO 302472 B1 NO302472 B1 NO 302472B1
Authority
NO
Norway
Prior art keywords
pharmaceutical formulation
sulfonylurea compound
provides
compound
dihydrobenzofuran
Prior art date
Application number
NO930380A
Other languages
English (en)
Norwegian (no)
Other versions
NO930380L (no
NO930380D0 (no
Inventor
George Bernard Boder
William Joseph Ehlhardt
Gerald Burr Grindey
John Eldon Toth
John Frederick Worzalla
John Lyle Zimmermann
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO930380D0 publication Critical patent/NO930380D0/no
Publication of NO930380L publication Critical patent/NO930380L/no
Publication of NO302472B1 publication Critical patent/NO302472B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Undergarments, Swaddling Clothes, Handkerchiefs Or Underwear Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO930380A 1992-02-05 1993-02-03 Sulfonylureaforbindelse, farmasöytisk formulering og anvendelse derav NO302472B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/831,604 US5254582A (en) 1992-02-05 1992-02-05 Antitumor compositions and methods

Publications (3)

Publication Number Publication Date
NO930380D0 NO930380D0 (no) 1993-02-03
NO930380L NO930380L (no) 1993-08-06
NO302472B1 true NO302472B1 (no) 1998-03-09

Family

ID=25259448

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930380A NO302472B1 (no) 1992-02-05 1993-02-03 Sulfonylureaforbindelse, farmasöytisk formulering og anvendelse derav

Country Status (25)

Country Link
US (1) US5254582A (pt)
EP (1) EP0555036B1 (pt)
JP (1) JP3210117B2 (pt)
KR (1) KR100246148B1 (pt)
CN (1) CN1044239C (pt)
AT (1) ATE170853T1 (pt)
AU (1) AU658043B2 (pt)
BR (1) BR9300469A (pt)
CA (1) CA2088719A1 (pt)
CY (1) CY2101B1 (pt)
CZ (1) CZ282753B6 (pt)
DE (1) DE69320844T2 (pt)
DK (1) DK0555036T3 (pt)
ES (1) ES2121940T3 (pt)
FI (1) FI930453A (pt)
HU (2) HU213231B (pt)
IL (1) IL104574A (pt)
MX (1) MX9300558A (pt)
MY (1) MY109640A (pt)
NO (1) NO302472B1 (pt)
NZ (1) NZ245818A (pt)
RU (1) RU2072996C1 (pt)
SG (1) SG79181A1 (pt)
YU (1) YU48915B (pt)
ZA (1) ZA93689B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
US5529999A (en) * 1994-03-04 1996-06-25 Eli Lilly And Company Antitumor compositions and methods of treatment
CA2263353C (en) * 1996-08-22 2002-04-23 Dong Wha Pharm. Ind. Co., Ltd. Arylsulfonylimidazolone derivatives as an antitumor agent
EP0929540A4 (en) * 1996-10-04 2001-12-12 Lilly Co Eli ANTI-TUMOR COMPOSITIONS AND THERAPEUTIC METHODS
US6281240B1 (en) * 1997-04-10 2001-08-28 Eli Lilly And Company Diarylsulfonylureas for use in treating secretory diarrhea
US5932407A (en) * 1997-04-30 1999-08-03 Eastman Kodak Company Color photographic element containing oxidized developer-scavenging naphtholic coupler forming wash-out dye
NZ580384A (en) 2003-07-23 2011-03-31 Bayer Pharmaceuticals Corp 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
JP5134247B2 (ja) * 2004-09-13 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有化合物の血管新生阻害物質との併用
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
EP2364699A1 (en) 2004-09-13 2011-09-14 Eisai R&D Management Co., Ltd. Joint use of sulfonamide based compound with angiogenesis inhibitor
US20100291592A1 (en) 2006-04-20 2010-11-18 Taro Semba Novel marker for sensitivity against sulfonamide compound
CN104941647B (zh) * 2015-06-18 2017-07-04 四川之江高新材料股份有限公司 合成n‑甲基吗啉的方法及所用的负载型催化剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3083207A (en) * 1963-03-26 Indolinesulfonylureas
US1208561A (en) * 1914-09-14 1916-12-12 Stephen E Huff Sound-box attachment for phonographs.
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
US3102121A (en) * 1961-06-29 1963-08-27 Olin Mathieson Novel cumaransulfonylureas and 2,3-dihydrothionaphthenesulfonylureas
NL295122A (pt) * 1962-04-11
US3849110A (en) * 1963-01-07 1974-11-19 Lilly Co Eli Herbicidal method employing aryl-sulfonylureas or salts thereof
US3736122A (en) * 1969-04-10 1973-05-29 C Tung Method of controlling plant growth
AU1862083A (en) * 1982-09-02 1984-03-08 Duphar International Research B.V. Tumor growth inhibitors
CA1208561A (en) * 1984-01-19 1986-07-29 Marius S. Brouwer Pharmaceutical compositions containing benzoylurea compounds
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
JPS6163671A (ja) * 1984-09-05 1986-04-01 Shionogi & Co Ltd ２，３−ジヒドロベンゾフラン−５−スルホンアミド誘導体および降圧利尿剤
GR862353B (en) * 1985-09-23 1987-01-19 Lilly Co Eli Anti-tumor method and compounds
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
CA1331464C (en) * 1987-05-12 1994-08-16 Eli Lilly And Company Anti-tumor method and compounds
IL98784A0 (en) * 1990-07-17 1992-07-15 Lilly Co Eli Heterocyclyl sulfonamide derivatives,process for their preparation and pharmaceutical compositions containing them
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment

Also Published As

Publication number Publication date
FI930453A (fi) 1993-08-06
CY2101B1 (en) 2002-04-05
DE69320844D1 (de) 1998-10-15
FI930453A0 (fi) 1993-02-02
HU9300288D0 (en) 1993-04-28
CZ12093A3 (en) 1993-12-15
KR100246148B1 (ko) 2000-04-01
JP3210117B2 (ja) 2001-09-17
AU658043B2 (en) 1995-03-30
MX9300558A (es) 1993-08-01
CN1044239C (zh) 1999-07-21
IL104574A (en) 1997-02-18
JPH05306277A (ja) 1993-11-19
DE69320844T2 (de) 1999-03-04
HU211561A9 (en) 1995-12-28
BR9300469A (pt) 1993-08-10
US5254582A (en) 1993-10-19
CZ282753B6 (cs) 1997-09-17
IL104574A0 (en) 1993-06-10
CA2088719A1 (en) 1993-08-06
HU213231B (en) 1997-03-28
EP0555036A2 (en) 1993-08-11
NO930380L (no) 1993-08-06
DK0555036T3 (da) 1999-06-07
YU5893A (sh) 1996-07-24
CN1075961A (zh) 1993-09-08
EP0555036A3 (en) 1993-11-24
KR930017885A (ko) 1993-09-20
ES2121940T3 (es) 1998-12-16
NO930380D0 (no) 1993-02-03
SG79181A1 (en) 2001-03-20
EP0555036B1 (en) 1998-09-09
NZ245818A (en) 1995-03-28
ZA93689B (en) 1994-08-01
ATE170853T1 (de) 1998-09-15
YU48915B (sh) 2002-11-15
MY109640A (en) 1997-03-31
HUT63842A (en) 1993-10-28
AU3218393A (en) 1993-08-12
RU2072996C1 (ru) 1997-02-10

Similar Documents

Publication Publication Date Title
CO4340622A1 (es) Nuevos macrociclos bis-indolil maleimida
MA26449A1 (fr) Derives d'acides amines .
ES2075040T3 (es) 2',3'-dideoxi-2',2'-difluoronucleosidos.
TW273550B (pt)
NO302472B1 (no) Sulfonylureaforbindelse, farmasöytisk formulering og anvendelse derav
IT1240336B (it) Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
RU93004535A (ru) Соединения, способ получения и фармацевтическая композиция на их основе
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
EP0515995A3 (en) N-(5-thioxo-l-prolyl)-l-cysteine, derivatives thereof, processes for the preparation thereof and pharmaceutical compositions containing them
ITMI910658A0 (it) N-(4,5-diidrossi-e 4,5,8-triidrossi-9,10-diidro-9,10-diosso-2- antracen-il)carbonil) amminoacidi utilizzabili nella terapia delle affezioni osteoarticolari
TR199900480T2 (xx) Kristalin farmas�tik �r�n.
ITMI911604A0 (it) Procedimento per la preparazione della n- (2,6-diclorofenil) -n-feniln- (cloroacetil) - ammina
IL98199A (en) Pharmaceutical compositions containing a derivative of substituted l-valyl-l-prolinamide
TH9193B (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
FR2693653B1 (fr) Compositions thérapeutiques à base de dérivés de la N-(phényléthyl-beta-ol) amine.
TH13149A (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
IT1282951B1 (it) Formulazioni farmaceutiche gastroresistenti contenenti colostro e uso del colostro per il trattamento dell'insonnia
TH13149EX (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
DE69111530D1 (de) Pyridincarbonsäure-Amid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
IT1254191B (it) Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina
ITMI911093A0 (it) Composizione farmaceutica contenente un'associazione di 3,4-di-o isobutirril-epinina ed isosorbide-5- monoidrato
ITMI910953A1 (it) Procedimento elettrochimico per la preparazione di lattami non sostituiti all'azoto

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2003